204 related articles for article (PubMed ID: 27351920)
21. Hematological malignancies in East Africa-Which cancers to expect and how to provide services.
Leak SA; Mmbaga LG; Mkwizu EW; Mapendo PJ; Henke O
PLoS One; 2020; 15(5):e0232848. PubMed ID: 32374771
[TBL] [Abstract][Full Text] [Related]
22. Cancer incidence in The Health Improvement Network.
Haynes K; Forde KA; Schinnar R; Wong P; Strom BL; Lewis JD
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):730-6. PubMed ID: 19479713
[TBL] [Abstract][Full Text] [Related]
23. A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data.
Wang HI; Roman E; Crouch S; Aas E; Burton C; Patmore R; Smith A
Value Health; 2018 Oct; 21(10):1176-1185. PubMed ID: 30314618
[TBL] [Abstract][Full Text] [Related]
24. Incidence and prevalence of acromegaly in a large US health plan database.
Burton T; Le Nestour E; Neary M; Ludlam WH
Pituitary; 2016 Jun; 19(3):262-7. PubMed ID: 26792654
[TBL] [Abstract][Full Text] [Related]
25. [Italian Cystic Fibrosis Register - Report 2010].
Amato A; Ferrigno L; Salvatore M; Toccaceli V;
Epidemiol Prev; 2016; 40(2 Suppl 2):1-47. PubMed ID: 27291389
[TBL] [Abstract][Full Text] [Related]
26. Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study.
Gradel KO; Nørgaard M; Dethlefsen C; Schønheyder HC; Kristensen B; Ejlertsen T; Nielsen H
Ann Hematol; 2009 Aug; 88(8):761-7. PubMed ID: 19083236
[TBL] [Abstract][Full Text] [Related]
27. Regional variation and challenges in estimating the incidence of giant cell tumor of bone.
Liede A; Bach BA; Stryker S; Hernandez RK; Sobocki P; Bennett B; Wong SS
J Bone Joint Surg Am; 2014 Dec; 96(23):1999-2007. PubMed ID: 25471915
[TBL] [Abstract][Full Text] [Related]
28. Cancer prevalence in the UK: results from the EUROPREVAL study.
Forman D; Stockton D; Møller H; Quinn M; Babb P; De Angelis R; Micheli A
Ann Oncol; 2003 Apr; 14(4):648-54. PubMed ID: 12649115
[TBL] [Abstract][Full Text] [Related]
29. Determinants of hospital death in haematological cancers: findings from a qualitative study.
McCaughan D; Roman E; Smith AG; Garry A; Johnson M; Patmore R; Howard M; Howell DA
BMJ Support Palliat Care; 2018 Mar; 8(1):78-86. PubMed ID: 28663341
[TBL] [Abstract][Full Text] [Related]
30. Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden.
Katz AJ; Chia VM; Schoonen WM; Kelsh MA
Cancer Causes Control; 2015 Nov; 26(11):1627-42. PubMed ID: 26376890
[TBL] [Abstract][Full Text] [Related]
31. Italian cancer figures--report 2006: 1. Incidence, mortality and estimates.
AIRT Working Group
Epidemiol Prev; 2006; 30(1 Suppl 2):8-10, 12-28, 30-101 passim. PubMed ID: 16826725
[TBL] [Abstract][Full Text] [Related]
32. Prevalence estimates for primary brain tumors in China: a multi-center cross-sectional study.
Jiang T; Tang GF; Lin Y; Peng XX; Zhang X; Zhai XW; Peng X; Yang JQ; Huang HE; Wu NF; Chen XJ; Xing HX; Su TY; Wang ZC
Chin Med J (Engl); 2011 Sep; 124(17):2578-83. PubMed ID: 22040406
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and clinical significance of neutropenia discovered in routine complete blood cell counts: a longitudinal study.
Andersen CL; Tesfa D; Siersma VD; Sandholdt H; Hasselbalch H; Bjerrum OW; Felding P; Lind B; Olivarius Nde F; Palmblad J
J Intern Med; 2016 Jun; 279(6):566-75. PubMed ID: 26791682
[TBL] [Abstract][Full Text] [Related]
34. Spectrum of haematologic malignancies and survival outcomes of adult lymphomas in Maiduguri, north eastern Nigeria--a fourteen year review.
Kagu MB; Ahmed SG; Bukar AA; Mohammed AA; Mayun AA; Musa AB
Afr J Med Med Sci; 2013 Mar; 42(1):5-14. PubMed ID: 23909089
[TBL] [Abstract][Full Text] [Related]
35. [Incidence of haematological neoplasms in Castilla y León, Spain].
Rodríguez-García JA; Vázquez L; Ramos F; Cuevas B; Martín A; Smucler A; Guerola DN; Cantalapiedra A; Alonso JM; Fernández S; Díez E; Rodríguez MJ; Calmuntia MJ; Aguilar C; Sierra M; Gracia JA; Cebeira MJ; Cantalejo R;
Med Clin (Barc); 2015 Jun; 144(11):491-500. PubMed ID: 25015251
[TBL] [Abstract][Full Text] [Related]
36. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
37. [Haematological malignancies (HM) in Basse-Normandie (BN): incidence and clinical and biological characteristics over the period 1997-2005 in patients less than 25 years old].
Collignon A; Duchenet V; Mouchel D; Malet M; Cornet E; Troussard X
Rev Epidemiol Sante Publique; 2012 Oct; 60(5):343-53. PubMed ID: 22981308
[TBL] [Abstract][Full Text] [Related]
38. Karachi Cancer Registry Data--implications for the National Cancer Control Program of Pakistan.
Bhurgri Y
Asian Pac J Cancer Prev; 2004; 5(1):77-82. PubMed ID: 15075010
[TBL] [Abstract][Full Text] [Related]
39. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract][Full Text] [Related]
40. Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.
Zhang AS; Ostrom QT; Kruchko C; Rogers L; Peereboom DM; Barnholtz-Sloan JS
Neuro Oncol; 2017 May; 19(5):726-735. PubMed ID: 28039365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
